HIGHLIGHTS
- who: Terry G. Dadzie from the University of Arkansas for Medical Sciences, United States have published the paper: The role of the bone microenvironment in regulating myeloma residual disease and treatment, in the Journal: (JOURNAL)
- what: The aim for the clinical management of myeloma is to achieve operational cure.
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
Similarly the anti-DKK1 antibody BHQ880 protected against development of myeloma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.